News
Popular searches: Influenza, Childhood cancer, Endometriosis, Inflammation
-
High blood pressure service increases referrals
A clinical service and primary care outreach program focused on hormonal causes of high blood pressure — the first of its kind in Victoria — has led to earlier screening and diagnosis of primary aldosteronism.… Read more
-
Reproductive health three minute thesis winners announced
Following a very successful CRH 3MT competition held via zoom last Wednesday, 20 May 2020, the prestigious judging panel, including Prof Jock Findlay, A/Prof Peter Stanton, Dr Tracey Edgell, Dr Rukmali Wijayarathna and Ann Scott, announced this year’s winners were… Read more
-
Pelvic organ prolapse treatment closer
A revolutionary technology to treat pelvic organ prolapse is one step closer after the latest results from a Hudson Institute study.… Read more
-
Crohn’s disease diagnosis impacts future health
Crohn’s disease is an incurable inflammatory bowel disease (IBD) affecting more than 60,000 Australians, including children.… Read more
-
Fetal growth restriction treatment findings
Treatments given postnatally to babies who have experienced fetal growth restriction (FGR) during pregnancy need to be carefully considered, following new light shed on the topic by cell therapy research.… Read more
-
NHMRC Investigator Grants success
Hudson Institute is delighted to announce the success of our researchers in the latest NHMRC Investigator Grant round. Internationally-renowned childhood sleep expert Professor Rosemary Horne has been awarded more than $2 million to pursue studies investigating the implications of impaired sleep on the developing brain, while Dr Jun Yang has been awarded more than half… Read more
-
$2.2 million awarded to tackle rare ovarian cancer
Women with a rare and potentially aggressive form of ovarian cancer will benefit from a grant to continue ground-breaking research into new detection and treatment methods.… Read more
-
Male infertility expert joins Hudson Institute
Dr Robin Hobbs has joined Hudson Institute as Group Head, Germline Stem Cell Biology. We welcome him and his team, including postdoctoral scientists Dr Ai-Leen Chan and Dr Julien Legrand, and PhD student Mai La.… Read more
-
Cell therapies trial planned for COVID-19
More than 200,000 people have died from COVID-19 since January 2020. While Australia has been relatively spared from the onslaught of infections and deaths, our nation’s scientists need to be part of the global effort to address this pandemic.… Read more
-
Using our immune system to fight COVID-19
There is something unusual about the initial—or innate—immune response to COVID-19 compared to usual influenza patterns. … Read more